REQUEST A DEMO
Total
USD $0.00
Search more companies

Neuroavances S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Neuroavances S.A.S. Profile Updated: May 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Neuroavances S.A.S. is a company based in Colombia, with its head office in Barranquilla. It operates in the Ambulatory Health Care Services sector. The enterprise was incorporated on April 06, 2013. The total number of employees is currently 33 (2023). From the latest financial highlights, Neuroavances S.A.S. reported a net sales revenue increase of 159.89% in 2023. Its’ total assets recorded a growth of 75.65%. The net profit margin of Neuroavances S.A.S. increased by 24.16% in 2023.

Headquarters
Cr 45 Cl 82 133
Barranquilla; Atlantico;

Contact Details: Purchase the Neuroavances S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Neuroavances S.A.S. report to view the information.
Outstanding Shares:
Purchase the Neuroavances S.A.S. report to view the information.
Incorporation Date:
April 06, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Neuroavances S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
159.89%
Total operating revenue
159.89%
Operating profit (EBIT)
414.76%
EBITDA
359.98%
Net Profit (Loss) for the Period
624.27%
Total assets
75.65%
Total equity
134.33%
Operating Profit Margin (ROS)
30.09%
Net Profit Margin
24.16%
Return on Equity (ROE)
43.84%
Debt to Equity Ratio
-27.93%
Quick Ratio
3.84%
Cash Ratio
2.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?